Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.4 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |